Patrick D. Yeramian

Companies

• Amylyx PharmaceuticalsChief Medical Officer Jan 6, 2022 to Jan 11, 2024¹
• BIOVIE INC.Chief Medical Officer Mar 13, 2019 to Oct 28, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Amylyx Pharmaceuticals AMLX205,605 shares³$5.6M at $27.07Jan 9, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 9, 2024Sold 2,812 shares at $16.33 of Amylyx Pharmaceuticals³
• May 15, 2023Sold 11,965 shares at $29.03 of Amylyx Pharmaceuticals⁴
• May 15, 2023Exercised options 9,764 shares at $6.88 of Amylyx Pharmaceuticals⁴
• May 15, 2023Exercised options 2,201 shares at $0.37 of Amylyx Pharmaceuticals⁴
• Apr 17, 2023Sold 300 shares at $30.94 of Amylyx Pharmaceuticals⁵
• Apr 17, 2023Sold 49,279 shares at $30.53 of Amylyx Pharmaceuticals⁵
• Apr 17, 2023Exercised options 4,718 shares at $6.88 of Amylyx Pharmaceuticals⁵
• Apr 17, 2023Exercised options 44,861 shares at $0.37 of Amylyx Pharmaceuticals⁵
• Mar 16, 2023Granted 9,167 shares of Amylyx Pharmaceuticals⁶
• Mar 16, 2023Sold 2,416 shares at $32.43 of Amylyx Pharmaceuticals⁶
• Mar 16, 2023Sold 52,211 shares at $31.85 of Amylyx Pharmaceuticals⁶
• Mar 16, 2023Exercised options 16,748 shares at $6.88 of Amylyx Pharmaceuticals⁶
• Mar 16, 2023Granted 9,167 shares of Amylyx Pharmaceuticals⁷
• Mar 16, 2023Exercised options 30,041 shares at $0.37 of Amylyx Pharmaceuticals⁶
• Mar 16, 2023Sold 2,416 shares at $32.43 of Amylyx Pharmaceuticals⁷
• Mar 16, 2023Exercised options 2,789 shares at $0.33 of Amylyx Pharmaceuticals⁶
• Mar 16, 2023Sold 52,211 shares at $31.85 of Amylyx Pharmaceuticals⁷
• Jan 6, 2023Sold 629 shares at $36.79 of Amylyx Pharmaceuticals⁸
• Jan 6, 2023Sold 1,405 shares at $36.08 of Amylyx Pharmaceuticals⁸
• Jan 6, 2022Granted 28,333 shares of Amylyx Pharmaceuticals⁹